• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Someone from Sun on a 'PR' mission

anonymous

Guest
In all of less than 3 minutes, I looked at the unusually high number of posts from 8:30 last night (as pointed out by someone else in the ZK thread) until just now.

It's crazy to see how some threads have been resurrected from way back in August and September, like out of the blue, and that there's a one-line 'positive' response. Clearly, the number and intensity of the posts here have gotten under someone's skin. One poster in the past 24h suggested the reason for the resurrected posts was to bury one particular post about ZK. But, that continued well through today.

Interesting factoid. Jeez, if Sun only applied these kinds of analytics to rebate programs, perhaps we'd be making more money.